192 results on '"Gupta, Shiv K."'
Search Results
2. Sectoral portfolio optimization by judicious selection of financial ratios via PCA
3. Editorial: Patient-derived tumor models for drug development
4. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
5. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
6. Optimality and duality results for a nondifferentiable multiobjective fractional programming problem
7. Symmetric duality for a higher-order nondifferentiable multiobjective programming problem
8. Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors
9. Abstract 2598: AZD1390 radio-sensitizes p53-mutant GBM via disrupting homology directed DNA repair
10. Cubic Polynomials with Rational Roots and Critical Points
11. Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
12. Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
13. Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor
14. Thermally assisted OSL: A potent tool for improvement in minimum detectable dose and extension of dose range of Al2O3:C
15. Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
16. Allocation of Effort Resources among Competing Activities
17. The Systems Approach in an Information Society: A Reconsideration
18. A Language for Policy-Level Modelling
19. Allocation of Marketing Effort Among P Substitutional Products in N Territories
20. Differential Equation Approach to Marketing
21. Mathematical Models in Marketing
22. A Note on the Partitioning of a Single Product Market into Territories of Outlets
23. A Note on Bomberger's Approach to Lot Size Scheduling: Heuristic Proposed
24. Robustness in Sequential Investment Decisions
25. Mathematical Model for a Duopolistic Market
26. Robustness and Optimality as Criteria for Strategic Decisions
27. Reply to Professor D. J. White
28. Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
29. In Vivo Efficacy of Tesevatinib in EGFR-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling
30. Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis
31. Conserved nucleotide sequences in highly expressed genes in plants
32. EXTH-01. INHIBITION OF DNA-PKcs BY M3814 POTENTIATES EFFICACY OF IONIZING RADIATION IN PATIENT-DERIVED XENOGRAFTS OF MELANOMA BRAIN METASTASES
33. TMOD-15. EFFICACY OF THE MDM2 INHIBITOR KRT-232 IN GLIOBLASTOMA PATIENT-DERIVED XENOGRAFT MODELS
34. Abstract 6276: Brain penetrant MDM2 inhibitor RG7388 extends survival benefit of radiation treatment in select glioblastoma patient-derived xenograft models
35. Abstract 6506: Targeting ATM with AZD1390 for radio-sensitization of glioblastoma patient derived xenografts
36. Abstract 1381: Inhibition of DNA-PKcs by M3814 potentiates efficacy of ionizing radiation in patient derived xenografts of melanoma brain metastases
37. Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b
38. Integrin α9β1: Unique signaling pathways reveal diverse biological roles
39. Editorial: Targeted Therapies for Glioblastoma: A Critical Appraisal
40. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
41. Molecular profiling of long-term IDH-wildtype glioblastoma survivors
42. Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
43. PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
44. Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor
45. A novel design for porphyrin based D–s–A systems as molecular rectifiers† †Electronic supplementary information (ESI) available: Schematic representation of the electro-grafting mechanism, the electrochemical deposition of undecene, I–V characteristics of the blank Si sample and C-11 alkyl monolayers on a silicon wafer, XPS of the monolayers and the optimised geometry of the 5b congener with reverse geometry. Tables of atom coordinates and absolute energies used for theoretical calculations. See DOI: 10.1039/c5sc03590b
46. Restricted delivery of talazoparib across the blood-brain barrier limits the sensitizing effects of poly (ADP-ribose) polymerase inhibition on temozolomide therapy in glioblastoma
47. Invex and quasi-invex NCP functions and their properties.
48. Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma
49. Evaluating Slot Machine Placement on the Casino Floor
50. International Environmental Problems: Systems Approach Used to Identify Scientific and Political Perceptions and Responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.